{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

2007 James D. Wolfensohn Award for International Person with MS winner announced!

The winner of the 2007 James D. Wolfensohn Award for International Person with MS is Ann Langley from Australia. As this year’s winner, Ann will attend MSIF's biennial Council, Board and Committee meetings and international Persons with MS Day to be held in Prague, Czech Republic from 8-10 October 2007. Ann will be presented with an MSIF certificate, and will speak about herself and what winning the award means to her, at the Council meeting. Please click here to read more.

Quality of life of people with MS

Does your MS society improve the quality of life of people with MS in your country? If so, we would like to hear from you.

read more

back to top

Profile of the Month : January 2008

Wendy Temple

Age: 49
Country: Australia
Occupation: Teacher
Year of diagnosis: 2003

"That would be my advice to anyone who has MS – there is always tomorrow. If you can’t do it today, try again tomorrow."

English Italiano Espanol Deutsch Francais Russian

read more

back to top

Disparities in the management of multiple sclerosis-related bladder symptoms

This study on more that 9,000 patients validated a new questionnaire to assess bladder and bowel function in people with MS. They found that ethnic and socioeconomic differences are present in the management of bladder problems.

authors: Marrie RA, Cutter G, Tyry T, Vollmer T, Campagnolo D.

source: Neurology. 2007 Jun 5

read more

Schwann cell precursors: a favourable cell for myelin repair in the Central Nervous System

The authors studied the effect of implanting peripheral myelin-producing cells in the central nervous system, at an early stage of their development, using a rat model of MS. They found the cells to be effective in producing new myelin in MS lesions.

authors: Woodhoo A, Sahni V, Gilson J, Setzu A, Franklin RJ, Blakemore WF, Mirsky R, Jessen KR

source: Brain. 2007 Jun 4

read more

Central histamine H3 receptor signaling negatively regulates susceptibility to autoimmune inflammatory disease of the CNS

The authors looked at the impact of a receptor for histamine in the development of the animal model of MS. They found that a reduced presence of this receptor in the central nervous system is related to the occurrence of a more severe disease in mice.

authors: Teuscher C, Subramanian M, Noubade R, Gao JF, Offner H, Zachary JF, Blankenhorn EP.

source: Proc Natl Acad Sci U S A. 2007 Jun 4

read more

Kinematic analysis of thalamic versus subthalamic neurostimulation in postural and intention tremor

The authors compared two different deep brain stimulation techniques to treat tremor caused by MS. They found one to be more effective than the other.

authors: Herzog J, Hamel W, Wenzelburger R, Potter M, Pinsker MO, Bartussek J, Morsnowski A, Steigerwald F, Deuschl G, Volkmann J.

source: Brain. 2007 Jun;130(Pt 6):1608-25.

read more

back to top

Austrian initiative: “Multiple SkleROSE” - a rose as a symbol against MS

source: Austrian MS Society

The MS Society of Vienna has now chosen a red rose as symbol for the resistance against the devasting effects of MS.

read more

Unproven goat serum treatment under the microscope

source: UK MS Society

The Guardian newspaper recently looked into concerns raised by the UK MS Society about the promotion and sale of Aimspro - a treatment derived from goat serum that is currently available on a specials licence to people with MS who are prepared to pay for it.

read more

MS trial alert: clinical trial of sex hormone estriol recruiting women with MS to participate

source: US National MS Society

In the first effort of its kind in MS, UCLA neurologist Dr Rhonda Voskuhl is leading a team of investigators at seven US medical centers to conduct a two-year, controlled clinical trial of a sex hormone added to standard therapy to treat MS.

read more

back to top

Tell a friend

The email you subscribed with us is {{print email}}

Within this newsletter the following options are available: MSIF News; People with MS News; Research News and MS Society News. To amend your options please login to the 'My world of MS' online community where you can also read diary entries from people affected by MS, leave your own diary entries and send messages to other users. You can also change your email address, contact details and subscribe to our free publications.

If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate.

If you do not want to receive future issues of this newsletter or if you have received this in error, please accept our apologies and simply unsubscribe here

Multiple Sclerosis International Federation
3rd Floor Skyline House, 200 Union Street, SE1 0LX
Tel: +44 (0) 20 7620 1911
Fax: +44 (0) 20 7620 1922
Registered Charity: 1105321
Email: info@msif.org

 Click here to learn more about the work of the Making Connections sponsor.